Incidence, risk factors and causality assessment for colistin-induced acute kidney injury among hospitalized patients in the State of Qatar: A multicenter retrospective study
Journal of Infection and Public Health · 2026
DOI: 10.1016/j.jiph.2026.103303 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Infection and Public Health, 2026. Verfasst von Duha Samer Akasheh und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, QU Health, Qatar University, Doha 2713, Qatar. Hauptthemen laut MEDLINE: Acute Kidney Injury, Colistin, Anti-Bacterial Agents. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hamad Medical Corporation, Qatar University.
Abstract (Originalsprache)
OBJECTIVE: To evaluate the incidence, causality and risk factors associated with colistin-induced acute kidney injury (AKI) using the Risk Injury Failure, Loss and End-stage renal disease (RIFLE) criteria. METHODS: This is a retrospective cohort study that involved patients treated with intravenous colistin from 2016 to 2023 in the State of Qatar. The Naranjo Scale was used for causality assessment. RESULTS: A total of 186 cases were included in this analysis. The incidence of colistin-induced AKI at day 14 was 23.7%. The median (interquartile range) time to AKI onset was 5.0 (7.0) days. Of the patients with AKI, 6 (12.8%) patients received renal replacement therapy within 30 days. Naranjo causality assessment showed that the majority of the cases (80.9%) had "possible" colistin-induced AKI (score 1 - 4). Colistin dose per administration (adjusted odds ratio [AOR]: 2.286, 95% CI: 1.246 - 4.194, p = 0.008), and sepsis/septic shock (AOR: 2.380, 95% CI: 1.005 - 5.635, p = 0.049) were independent risk factors for colistin-induced AKI. CONCLUSION: One in four patients receiving colistin develops AKI, and a subset required a renal replacement therapy within 30 days. Close monitoring of patients, and the application of precision medicine are recommended to minimize the risk of AKI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, QU Health, Qatar University, Doha 2713, Qatar.
- Department of Pharmacy, Hamad Medical Corporation, Doha, Qatar.
- Department of Medicine, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
- Department of Medicine, Infectious Diseases Division, Al-Wakra Hospital, Hamad Medical Corporation, Doha, Qatar; College of Medicine, QU Health, Qatar University, P. O. Box 2713, Doha, Qatar.
- Department of Clinical Pharmacy and Practice, College of Pharmacy, QU Health, Qatar University, P. O. Box 2713, Doha, Qatar. Electronic address: usman.abubakar@qu.edu.qa.
Förderung
- Hamad Medical Corporation
- Qatar University
Zitieren
APA
Akasheh, D. S., Abu Asfour, N. A., Elajez, R., Mohammad, M. Z., Chaponda, M., Mohamed, A. E. M., & Abubakar, U. (2026). Incidence, risk factors and causality assessment for colistin-induced acute kidney injury among hospitalized patients in the State of Qatar: A multicenter retrospective study. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2026.103303
Vancouver
Akasheh DS, Abu Asfour NA, Elajez R, Mohammad MZ, Chaponda M, Mohamed AEM, et al. Incidence, risk factors and causality assessment for colistin-induced acute kidney injury among hospitalized patients in the State of Qatar: A multicenter retrospective study. Journal of Infection and Public Health. 2026. doi:10.1016/j.jiph.2026.103303
BibTeX
@article{Akasheh2026,
author = {Akasheh, Duha Samer and Abu Asfour, Nour Abdallah and Elajez, Reem and Mohammad, Mohammad Zeyad and Chaponda, Masautso and Mohamed, Asmaa Ezzeldin Mohd and Abubakar, Usman},
title = {Incidence, risk factors and causality assessment for colistin-induced acute kidney injury among hospitalized patients in the State of Qatar: A multicenter retrospective study},
journal = {Journal of Infection and Public Health},
year = {2026},
doi = {10.1016/j.jiph.2026.103303}
}
EUVIMED